Abstract
Toxin neutralizing antibodies represent the major mode of protective immunity against a number of toxin-mediated bacterial diseases, including anthrax; however, the cellular mechanisms that lead to optimal neutralizing antibody responses remain ill defined. Here we show that the cellular binding pathway of anthrax protective antigen (PA), the binding component of anthrax toxin, determines the toxin neutralizing antibody response to this antigen. PA, which binds cellular receptors and efficiently enters antigen-presenting cells by receptor-mediated endocytosis, was found to elicit robust anti-PA IgG and toxin neutralizing antibody responses. In contrast, a receptor binding-deficient mutant of PA, which does not bind receptors and only inefficiently enters antigen-presenting cells by macropinocytosis, elicited very poor antibody responses. A chimeric protein consisting of the receptor binding-deficient PA mutant tethered to the binding subunit of cholera toxin, which efficiently enters cells using the cholera toxin receptor rather than the PA receptor, elicited an anti-PA IgG antibody response similar to that elicited by wild-type PA; however, the chimeric protein elicited a poor toxin neutralizing antibody response. Taken togeth...Continue Reading
References
Jul 1, 1991·Molecular Microbiology·M G Jobling, R K Holmes
Dec 1, 1983·Microbiological Reviews·L EidelsD A Hart
Aug 25, 1995·Journal of Molecular Biology·R G ZhangE M Westbrook
Dec 1, 1993·The Journal of Cell Biology·L H WangR G Anderson
Feb 24, 2001·Cellular Microbiology·K E BeauregardJ A Swanson
Sep 6, 2001·Vaccine·M L PittA M Friedlander
May 29, 2003·The Journal of Biological Chemistry·M J RosovitzStephen H Leppla
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
May 20, 2004·International Journal of Medical Microbiology : IJMM·Wayne I Lencer
Sep 1, 2004·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Sep 29, 2005·The Journal of Biological Chemistry·Gil ZomberEytan Elhanany
Nov 16, 2005·Immunity·Amy BergtoldRaphael Clynes
Nov 30, 2005·Immunology·Kakali SarkarStephen Shaw
Jun 17, 2006·Science·Hai QiRonald N Germain
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Jan 15, 2008·Vaccine·Ming YanJulia Y Wang
Apr 18, 2008·Clinical and Vaccine Immunology : CVI·Kristian S OmlandUNKNOWN Participating Laboratories
Dec 17, 2008·Nature Reviews. Immunology·Facundo D Batista, Naomi E Harwood
Jul 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Shihui LiuStephen H Leppla
Apr 9, 2010·Clinical and Vaccine Immunology : CVI·Miriam M NgundiDrusilla L Burns
Mar 1, 2010·Toxins·Naomi L B WernickWayne I Lencer
Jul 21, 2012·Clinical and Vaccine Immunology : CVI·Leslie WagnerDrusilla L Burns
Aug 11, 2012·PloS One·Gregory A Price, Randall K Holmes
Nov 2, 2012·Infection and Immunity·Anita VermaDrusilla L Burns
May 10, 2013·Clinical and Vaccine Immunology : CVI·Boris IoninMario H Skiadopoulos
Jun 19, 2013·Immunity·Balthasar A HeestersMichael C Carroll
Sep 5, 2014·Clinical and Vaccine Immunology : CVI·Ligong ChenConrad P Quinn
Sep 5, 2014·Biochemistry·Vennela MullangiMasaru Miyagi
Dec 4, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bettina Eide HolmNicole Hartwig Trier
Mar 16, 2016·Toxins·Sarah FriebeJérôme Bürgi